A multi-centre EU third phase trial required on short notice large volumes of a comparator product by AstraZeneca. CliniSped organized within a month the full quantity required in single batch with product documents
Clinical trial company required a facility in Europe to consolidate EU comparator products. CliniSped facilities were used and through dedicated transport, could expedite direct to multiple sites across Europe.
CRO required samples of 8 different batches from the originator. Whilst consolidating batches onsite to reduced outgoing cold chain costs, CliniSped could fulfill the requirement through a network of EU agents